To access this element change to forms mode OFF
Grant Award View - GA29692
Investigating the role of the immunity in HER2-positive breast ductal...
GA ID:
GA29692
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Mar-2021
Value (AUD):
$96,293.75
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Investigating the role of the immunity in HER2-positive breast ductal carcinoma in situ and invasive ductal carcinoma and response to HER2 targeted treatment
Purpose:
Breast cancer is the most commonly diagnosed cancer in females in Australia and its incidence continues to increase. There is emerging evidence that immune cells play an important role in fighting particular subtypes of breast cancer (HER2-positive and triple negative). Currently, there is no immunotherapy available in the treatment of breast cancer. We aim to investigate the role of the immune microenvironment in the treatment of HER2-positive breast cancer.
GO ID:
GO Title:
NHMRC Postgraduate Scholarships for funding commencing in 2019
Internal Reference ID:
GNT1168567
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA